An FDA advisory committee is scheduled to meet on December 10 to discuss Pfizer Inc.’s request. To obtain an emergency use license.
The head of US efforts to produce a vaccine for the Coronavirus, said that the first immunization could take place on December 12.
An FDA advisory committee is scheduled to meet on December 10 to discuss Pfizer Inc.’s request. To obtain an emergency use license to develop a COVID-19 vaccine.
Pfizer and its German partner BioNTech recently announced that the vaccine appears to be 95% effective in preventing mild to severe COVID-19 disease in a large, ongoing study.
Dr. Moncef Salawi, head of Operation Warp Speed, the Coronavirus Vaccine Program, says that the plans aim to ship the vaccines to the states within 24 hours of the expected approval of the US Food and Drug Administration.
Al-Salawi told CNN that he expects vaccinations to begin on the second day after approval, December 12th.
Pfizer formally asked US regulators Friday to allow emergency use of its COVID-19 vaccine, starting the watch in a process that could bring in limited first shots as early as next month and ultimately ending the pandemic – but not until after a long, harsh winter.
As the Coronavirus spreads across the United States and the world, pressure is mounting on regulators to take a quick decision.
“Help is on the way,” said Dr. Anthony Fauci, the chief US infectious disease expert, on the eve of Pfizer’s announcement, adding that it was too early to abandon masks and other preventive measures. “We actually need to double down on public health measures while we wait for that help to arrive.”
Friday’s deposit kicks off a series of events as the FDA and its independent advisors debate whether the footage is ready. If so, another government group has yet to decide how to distribute the limited initial supplies to anxiously waiting Americans.
How much vaccine is available and when it is a moving target, but initial supplies will be scarce and fortified. Globally, Pfizer estimates that it may have 50 million doses available by the end of the year.
Lauren Nergard contributed to this report.